The development of a direct homologous radioimmunoassay for serum cortisol - PubMed

The development of a direct homologous radioimmunoassay for serum cortisol

G K Stalla et al. J Clin Chem Clin Biochem. 1981 Jul.

Abstract

This article describes the synthesis of a pure cortisol-3-(O-carboxymethyl) oxime with its subsequent use in producing highly specific antibodies and a 125I-tracer with a shelf life in excess of several weeks. An assay was developed using a pH of 4, thus allowing a direct measurement of cortisol in serum without extraction or heat denaturation. The quality-control parameters were checked - the intra-assay C.V. in the working range (area of clinical interest) was under 5%, and the interassay C.V. under 11%. Correlation studies with results using other antisera and with 3H-tracer are highly significant with the slope of the regression curve deviating less than 2% from the ideal volume. Finally the assay is fully automatable and is suitable for most automatic pipetting and analysis systems.

Similar articles

• A simple, direct radioimmunoassay for plasma cortisol, featuring a 125I radioligand and a solid-phase separation technique.

  Riad-Fahmy D, Read GF, Gaskell SJ, Dyas J, Hindawi R. Riad-Fahmy D, et al. Clin Chem. 1979 May;25(5):665-8. Clin Chem. 1979. PMID: 436230

• Determination of cortisol in human plasma by radioimmunoassay. Use of the 125I-labelled radioligand.

  Read GF, Fahmy DR, Walker RF. Read GF, et al. Ann Clin Biochem. 1977 Nov;14(6):343-9. doi: 10.1177/000456327701400189. Ann Clin Biochem. 1977. PMID: 596816

• One step enzyme linked immunosorbent assay for direct estimation of serum cortisol.

  Basu A, Shrivastav TG. Basu A, et al. J Immunoassay. 2000 Feb;21(1):39-50. doi: 10.1080/01971520009349498. J Immunoassay. 2000. PMID: 10805317

• Problems affecting radioimmunoassay procedures.

  Spierto FW, Shaw W. Spierto FW, et al. CRC Crit Rev Clin Lab Sci. 1977 Jun;7(4):365-72. doi: 10.3109/10408367709151689. CRC Crit Rev Clin Lab Sci. 1977. PMID: 71227 Review. No abstract available.

Cited by

• The influence of dexamethasone on growth hormone (GH). Response to GH-releasing hormone in normal men.

  Rupprecht R, Niehaus A, Lesch KP. Rupprecht R, et al. J Neural Transm Gen Sect. 1990;79(1-2):51-7. doi: 10.1007/BF01251000. J Neural Transm Gen Sect. 1990. PMID: 2105096

• Metabolic and hormonal studies of type 1 (insulin-dependent) diabetic patients after successful pancreas and kidney transplantation.

  Landgraf R, Nusser J, Riepl RL, Fiedler F, Illner WD, Abendroth D, Land W. Landgraf R, et al. Diabetologia. 1991 Aug;34 Suppl 1:S61-7. doi: 10.1007/BF00587622. Diabetologia. 1991. PMID: 1936698 Clinical Trial.

• Combined pituitary function-test with four hypothalamic releasing hormones.

  Schopohl J, Losa M, König A, Müller OA, Stalla GK, von Werder K. Schopohl J, et al. Klin Wochenschr. 1986 Apr 1;64(7):314-8. doi: 10.1007/BF01711949. Klin Wochenschr. 1986. PMID: 3012190

• Corticotropin releasing factor (CRF)-stimulation test in normal controls and patients with disturbances of the hypothalamo-pituitary-adrenal axis.

  Müller OA, Dörr HG, Hagen B, Stalla GK, von Werder K. Müller OA, et al. Klin Wochenschr. 1982 Dec 15;60(24):1485-91. doi: 10.1007/BF01716099. Klin Wochenschr. 1982. PMID: 6300509

• Clinical and biochemical features of patients with aldosterone-producing adenoma and idiopathic hyperaldosteronism.

  Witzgall H, Müller OA, Weber PC. Witzgall H, et al. Klin Wochenschr. 1983 Jan 3;61(1):35-42. doi: 10.1007/BF01484437. Klin Wochenschr. 1983. PMID: 6834744 No abstract available.

Publication types

MeSH terms

Substances